TETRAPHASE PHARMACEUTICALS I - COM (TTPH)

CUSIP: 88165N105

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / COM
Total 13F shares
20,217,056
Share change
-1,600,696
Total reported value
$77,432,668
Put/Call ratio
35%
Price per share
$3.83
Number of holders
89
Value change
-$6,326,626
Number of buys
35
Number of sells
37

Quarterly Holders Quick Answers

What is CUSIP 88165N105?
CUSIP 88165N105 identifies TTPH - TETRAPHASE PHARMACEUTICALS I - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TETRAPHASE PHARMACEUTICALS I - COM (TTPH) as of Q3 2016

As of 30 Sep 2016, TETRAPHASE PHARMACEUTICALS I - COM (TTPH) was held by 89 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 20,217,056 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, CANADA PENSION PLAN INVESTMENT BOARD, BlackRock Fund Advisors, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., NORTHERN TRUST CORP, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, and ARMISTICE CAPITAL, LLC. This page lists 89 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.